These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Repeated oral co-exposure to yessotoxin and okadaic acid: a short term toxicity study in mice. Sosa S; Ardizzone M; Beltramo D; Vita F; Dell'Ovo V; Barreras A; Yasumoto T; Tubaro A Toxicon; 2013 Dec; 76():94-102. PubMed ID: 24060376 [TBL] [Abstract][Full Text] [Related]
7. Ultrastructural damage to heart tissue from repeated oral exposure to yessotoxin resolves in 3 months. Tubaro A; Giangaspero A; Ardizzone M; Soranzo MR; Vita F; Yasumoto T; Maucher JM; Ramsdell JS; Sosa S Toxicon; 2008 Jun; 51(7):1225-35. PubMed ID: 18402996 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of yessotoxin on a primary culture of rat cardiomyocytes. Dell'Ovo V; Bandi E; Coslovich T; Florio C; Sciancalepore M; Decorti G; Sosa S; Lorenzon P; Yasumoto T; Tubaro A Toxicol Sci; 2008 Dec; 106(2):392-9. PubMed ID: 18799716 [TBL] [Abstract][Full Text] [Related]
12. In vitro chronic effects on hERG channel caused by the marine biotoxin azaspiracid-2. Ferreiro SF; Vilariño N; Louzao MC; Nicolaou KC; Frederick MO; Botana LM Toxicon; 2014 Dec; 91():69-75. PubMed ID: 25286396 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of yessotoxin and okadaic acid in mouse T lymphocyte cell line EL-4. Martín-López A; Gallardo-Rodríguez JJ; Sánchez-Mirón A; García-Camacho F; Molina-Grima E Toxicon; 2012 Nov; 60(6):1049-56. PubMed ID: 22858382 [TBL] [Abstract][Full Text] [Related]
14. Yessotoxin, a Promising Therapeutic Tool. Alfonso A; Vieytes MR; Botana LM Mar Drugs; 2016 Jan; 14(2):. PubMed ID: 26828502 [TBL] [Abstract][Full Text] [Related]
15. Oral and intraperitoneal acute toxicity studies of yessotoxin and homoyessotoxins in mice. Tubaro A; Sosa S; Carbonatto M; Altinier G; Vita F; Melato M; Satake M; Yasumoto T Toxicon; 2003 Jun; 41(7):783-92. PubMed ID: 12782078 [TBL] [Abstract][Full Text] [Related]
16. Yessotoxin, a shellfish biotoxin, is a potent inducer of the permeability transition in isolated mitochondria and intact cells. Bianchi C; Fato R; Angelin A; Trombetti F; Ventrella V; Borgatti AR; Fattorusso E; Ciminiello P; Bernardi P; Lenaz G; Parenti Castelli G Biochim Biophys Acta; 2004 Jun; 1656(2-3):139-47. PubMed ID: 15178475 [TBL] [Abstract][Full Text] [Related]
17. First report on azaspiracid and yessotoxin groups detection in French shellfish. Amzil Z; Sibat M; Royer F; Savar V Toxicon; 2008 Jul; 52(1):39-48. PubMed ID: 18573273 [TBL] [Abstract][Full Text] [Related]
18. Combined oral toxicity of azaspiracid-1 and yessotoxin in female NMRI mice. Aasen JA; Espenes A; Miles CO; Samdal IA; Hess P; Aune T Toxicon; 2011 May; 57(6):909-17. PubMed ID: 21426911 [TBL] [Abstract][Full Text] [Related]
19. Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol. Yoon KS; Lee JM; Kim YH; Suh SK; Cha HJ Toxicol Lett; 2020 Feb; 319():40-48. PubMed ID: 31706004 [TBL] [Abstract][Full Text] [Related]
20. Oral administration of yessotoxin stabilizes E-cadherin in mouse colon. Callegari F; Sosa S; Ferrari S; Soranzo MR; Pierotti S; Yasumoto T; Tubaro A; Rossini GP Toxicology; 2006 Oct; 227(1-2):145-55. PubMed ID: 16950554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]